Welcome to our new website
Cookies
We use cookies to help provide you with the best possible online experience. Please read our updated Privacy Policy and Terms of Use for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Patient safety incidents are unintended/unexpected, which could have, or did, lead to harm for one or more patients receiving healthcare.
Pharmacy teams must report incidents , whether they result in harm or not. The NPA patient safety reporting form is quick and convenient to use. Before submitting, the form can be printed, or emailed, to be kept in-line with professional standards.
Patient Safety News
NPA Patient Safety SOPs
Drug alerts, medicine recalls and company drug alerts and recalls
|
Community pharmacy Incident Reporting Pharmacy teams must report incidents, whether they result in harm or not. The NPA patient safety reporting form is quick and convenient to use. Before submitting, the form can be printed, or emailed, to be kept in-line with professional standards. We strongly advise all community pharmacy teams to ensure compliance with NHS/clinical governance and GPhC/PSNI requirements. Ensure that all staff, including temporary and agency staff:
Share learnings from the incident and implement any actions required |
|
The professional duty of candour The General Pharmaceutical Council (GPhC) and the Pharmaceutical Society of Northern Ireland (PSNI) have previously issued a joint statement with other regulators about the professional duty of candour and the importance of being open and honest with patients when something goes wrong with their treatment or care which causes or has the potential to cause harm or distress. Pharmacists and pharmacy technicians must:
The joint statement also states: |
| Report an incident:
|
England:
| In September 2014, NHS England (now NHS England & NHS Improvement), and the MHRA, issued a Stage Three Directive recommending all large community pharmacy organisations (as well as NHS Trusts, homecare companies and independent providers) to identify a named Medication Safety Officer (MSO) to review medication incidents and oversee safety improvement. Most of the MSOs in community pharmacy organisations are the Superintendent Pharmacist, or a senior member of their team, and are also the point of contact for safety for their pharmacy teams located outside of England.
The National Pharmacy Association (NPA) also appointed an MSO to fulfil this role for community pharmacies with fewer than 50 branches. Jasmine Shah (Head of Advice & Support Services, NPA) has been appointed to this role currently Contact the NPA MSO NPA members Independent community pharmacies in England, who are NPA members, can contact the NPA MSO, Jasmine Shah (Head of Advice and Support Services), through the Pharmacy Services Team at the NPA for further information, advice and/or support on any patient safety or pharmacy topic/matter by:
Non-members Independent community pharmacies in England with fewer than 50 branches who are currently not members of the NPA can contact the NPA MSO by:
|
Scotland:
| NPA Incident Reporting Platform Scotland | Medication Safety Update reports Scotland
Medication safety updates presenting our analysis of patient safety incidents reported |
Scottish Patient Safety Programme |
| Duty of Candour (Scotland) – Annual Report Template |
Wales:
| Patient Safety Wales
The NHS Wales Delivery Unit supports organisations in NHS Wales in improving safety and quality, developing safer environments and reducing avoidable harm. |
National Patient Safety Incident Reporting Policy (Welsh Government, May 2021)
The national incident reporting in NHS Wales has changed from June 2021. |
Welsh Government
Monthly Patient safety data |
Northern Ireland:
| Patient Safety Incident Reporting tool | HSC Medicines Governance NI
Annoymous Reporting of adverse incidents by Community Pharmacy Services |
Department of Health
Transforming medication safety in Northern Ireland |
The MHRA dedicated site for reporting suspected problem or incidence to medicines and medical devices.
The MHRA dedicated site for healthcare professionals, patients and carers are asked to report all suspected side effects to medicines or medical device adverse incidents related to COVID-19 treatment, including COVID-19 vaccines.